TP53 and cancer: In one study, the reduced stability of p53 in metformin-treated individuals led to a decrease in differentiated embryo chondrocyte 1 (DEC1) expression, which plays a crucial role in the DNA-damage response via transcriptional regulation under hypoxic conditions and the induction of cancer cell apoptosis [19,21,119].